Reduction of cardiac endothelin-1 by angiotensin II type1 receptor antagonist in viral myocarditis of mice

Life Sciences

Volumn 67, Issue 5, 2000, Pages 587-597

  Baba, Toshiaki ^a   Kanda, Tsugiyasu ^a   Kobayashi, Isao ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin II type1 receptor (ATI) antagonist; Endothelin 1; Myocarditis

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CAPTOPRIL; ENALAPRIL; ENDOTHELIN 1; MESSENGER RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS MYOCARDITIS;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIOVIRUS INFECTIONS; ENCEPHALOMYOCARDITIS VIRUS; ENDOTHELIN-1; FEMALE; MICE; MICE, INBRED C3H; MYOCARDITIS; ORGAN SIZE; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034705546     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)00654-8     Document Type: Article

References (30)

1. M.A. Bogoyevitch, B.J. Gillespie, A.J. Ketterman, S.J. Fuller, L.R. Ben, A. Ashworth, C.J. Marshall, and P.H. Sugden, Circ. Res. 79 162-73 (1996).
2. T. Yamazaki, I. Komuro, S. Kudoh, Y. Zou, I. Shiojima, Y. Hiroi, T. Mizuno, K. Maemura, H. Kurihara, R. Aikawa, H. Takano, and Y. Yazaki, J. Biol. Chem. 271 3221-8 (1996).
3. W.S. Colucci, Circulation. 93 1069-72 (1996).
4. T. Tonnessen, G. Christensen, E. Oie, E. Holt, H. Kjekshus, O.A. Smiseth, O.M. Sejersted, and H. Attramadal, Cardiovasc. Res. 33 601-10 (1997).
5. H. Ito, Y. Hirata, S. Adachi, M. Tanaka, M. Tsujino, A. Koike, A. Nogami, F. Murumo, and M. Hiroe, J. Clin. Invest. 92 398-403 (1993).
6. M. Araki, T. Kanda, S. Imai, T. Suzuki, K. Murata, and I. Kobayashi, J. Cardiovasc. Pharmacol. 26 61-5 (1995).
7. S. Sakai, T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita, Nature. 384 353-5 (1996).
8. S. Sakai, T. Miyauchi, T. Sakurai, Y. Kasuya, M. Ihara, I. Yamaguchi, K. Goto, and Y. Sugishita, Circulation. 93 1214-22 (1996).
9. T. Kanda, T. Yokoyama, S. Imai, T. Suzuki, R. Nagai, and I. Kobayashi. J Pharmacol Exp Ther. 274 494-8 (1996).
10. T. Kanda, I. Kobayashi, T. Suzuki, K. Murata, S.J. Radio, and B.M. McManus, J. Med. 26 153-62 (1995).
11. A. Matsumori, and C. Kawai, Circulation. 65 1230-5 (1982).
12. Y.H. Lui, X.P. Yang, V.G. Sharov, O. Nass, H.N. Sabbah, E. Peterson, and O.A. Carretero, J. Clin. Invest. 99 1926-35 (1997).
13. D.D. Borgeson, J.A. Grantham, E.E. Williamson, A. Luchner, M.M. Redfield, T.J. Opgenorth, and J.C. Burnett, Hypertension. 31 766-70 (1998).
14. A.S. Pandey, D.J. Stewart, P. Cernacek, F. Dawood, W.H. Wen, and P. Liu, J. Cardiovasc. PharMacol. 31 Suppl 1 S306-8 (1998).
15. T.B. Chen, V.J. Lotti, and R.S. Chang, Mol. Pharmacol. 42 1077-82 (1992).
16. R.S. Chang, P.K. Siegel, B.V. Clineschmidt, N.B. Mantlo, P.K. Chakravarty, W.J. Greenlee, A.A. Patchett, and V.J. Lotti, J. Pharmacol. Exp Ther. 262 133-8 (1992).
17. T. Kanda, S. Imai, T. Suzuki, R. Nagai, and I. Kobayashi, Circ. Res. 78 848-856 (1996).
18. P.C. Wong, S.D. Hart, A.M. Zaspel, A.T. Chiu, R.J. Ardecky, R.D. Smith, and P.B. Timmermans, J. Pharmacol. Exp. Ther. 255 584-92 (1990).
19. N.B. Mantlo, P.K. Chakrayarty, D.L. Ondeyka, P.K. Siegl, R.S. Chang, V.J. Lotti, K.A. Faust, T.B. Chen, T.W. Schorn, C.S. Sweet, S.E. Emmert, A.A. Patvhett, and W.J. Greenlee, J. Med. Chem. 34, 2919-2922 (1991).
20. R. Iwata, T. Hayashi, Y. Nakao, M. Yamaki, T. Yoshimasa, H. Ito, Y. Saito, M. Mukoyama, and K. Nakao, Clin. Chem. 42 1155-1158 (1996).
21. K. Ishibashi, T. Kashiwagi, A. Ito, Y. Tanaka, T. Nagata, J. Tamaki, M. Azuma, Y. Kishida, A. Yoshida, and A.Y. Hikiji, Hepatogastroenterology 42 535-41 (1995).
22. D.J. Stewart, P. Cernacek, K.B. Costello, and J.L. Rouleau, Circulation. 85 510-7 (1992).
23. W. Kiowski, G. Sutsch, P. Hunziker, P. Muller, J. Kim, E. Oechslin, R. Schmitt, R. Jones, and O. Bertel, Lancet. 346 732-6 (1995).
24. D.D. Borgeson, J.A. Grantham, E.E. Williamson, A. Luchner, M.M. Redfield, T.J. Opgenorth, and J.C. Burnett, Hypertension 31 766-770 (1998).
25. G. Sutsch, O. Bertel, and W. Kiowski, Cardiovasc. Drugs. Ther. 10 717-25 (1997).
26. B. Pitt, R. Segal, F.A. Martinez, G. Meurers, A.J. Cowley, I. Thomas, P.C. Deedwania, D.E. Ney, D.B. Snavely, and P.I. Chang, Lancet. 349 747-52 (1997).
27. H. Suzuki, A. Matsumori, Y. Matoba, B.S. Kyu, A. Tanaka, J. Fujita, and S. Sasayama, J. Clin. Invest. 91 2727-33 (1993).
28. S. Rezkalla, R.A. Kloner, G. Khatib, and R. Khatib, Circulation 81 1039-46 (1990).
29. E.M. De Cayanagh, C.G. Fraga, L. Ferder, and F. Inserra, Am. J. Physiol. 272 R514-8 (1997).
30. N.B. Matlo, P.K. Chakravarty, D.L. Ondeyka, P.K. S. Siegl, R.S. Chang, V.J. Lotti, K.A. Faust, T-B. Cheng, T.W. Schorn, C.S. Sweet, S.E. Emmert, A.A. Patchett, and W.J. Greenlee, J Med Chem. 34 2919-22 (1991).